Home/Filings/4/0001638599-17-000178
4//SEC Filing

ALBANY MOLECULAR RESEARCH INC 4

Accession 0001638599-17-000178

CIK 0001065087operating

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:05 PM ET

Size

8.3 KB

Accession

0001638599-17-000178

Insider Transaction Report

Form 4
Period: 2017-02-08
Transactions
  • Award

    Common Stock

    2017-02-08+3,8026,656 total
  • Award

    Option to Purchase Common Stock

    2017-02-08+9,3589,358 total
    Exercise: $18.41Exp: 2027-02-08Common Stock (9,358 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,200,000
Footnotes (2)
  • [F1]These shares are held directly by 3-Gutinver, S.L., a company organized and existing under the laws of Spain. The Reporting Person is the Sole Administrator of 3-Gutinver, S.L. and may be deemed to beneficially hold these securities in such capacity. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed and admission that the Reporting Person is the beneficial owner of such securities for the purposes of Section 16 or any other purpose.
  • [F2]Option is exercisable as to 1/3rd of the shares annually on the anniversary date of the grant for each of the next three years.

Issuer

ALBANY MOLECULAR RESEARCH INC

CIK 0001065087

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001065087

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:05 PM ET
Size
8.3 KB